AxoGen (AXGN) announced positive topline results from a phase 3 study for the Avance Nerve Graft. President, CEO, and Chairman Karen Zaderej weighs in on the tissue product moving into the biological category. Avance Nerve Graft would be used whenever a nerve is cut anywhere on the body and in the peripheral nervous system. This would repair the nerve. Nerve damage can occur from kitchen knives to vehicle accidents to power tools.
21 Nov 2022
Morning Trade Live
15 Sep 2023
Market On Close
09 Nov 2023
Trading 360
09 Nov 2023
Market On Close
24 Oct 2023
The Watch List
21 Sep 2023
The Watch List
02 Oct 2023